Mealey's (January 11, 2019, 1:18 PM EST) -- WASHINGTON, D.C. — An appeal of a Delaware federal judge’s determination that a patented pharmaceutical tablet with a core composed of a “macroscopically homogenous composition” for controlling the release of budesonide...
Oral Arguments Held In Dispute Over Controlled Release Budesonide Tablet
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login